Faculty scientist at nscri.in

Arijit Ghosh

MSc. Biochemistry (Field Assistant (2024))

Expertise

WORKING ON AN ONGOING PROJECT: A study of prognostic risk-assessment analysis and disease monitoring through blood-based MALAT1 expression in association with perineural invasion and lymphovascular invasion in oral squamous cell carcinoma” FUNDED BY LADY TATA MEMORIAL TRUST under Dr. Ruma Dey Ghosh

AWARDS: “Travel Grant Award” from ESMO Asia 2016 (Singapore).

                   “Young Scientist Award” at PACCS 2018 (Kolkata).

PUBLICATIONS:

 

  1. Bhattacharya R, Ghosh A, Mukhopadhyay S. “High-grade serous ovarian carcinoma, the “Achiles’ hill” for clinicians and molecular biologists: a molecular insight”. Molecular Biology Reports. (2023) (IF - 2.8)
  2. Singh R, Chandel S, Ghosh A, Matta T, Gautam A, Bhattacharya A, Babu SS, Sukla S, Nag D, Ravichandiran V, Roy S. “Glucogallin attenuates the LPS-induced signaling in macrophages and protects mice against Sepsis”. International Journal of Molecular Sciences. (2022) (IF – 5.6)
  3. Khan AN, Singh R, Bhattacharya A, Kumar S, Ghosh A, Nag D, Ravichandiran V, Ghosh D. “Glucogallin Attenuates RAW 264.7 Cells from Arsenic Trioxide Induced Toxicity via the NF-ҡB/NLRP3 Pathway”. Molecules. (2022) (IF – 4.6)
  4. Tangelloju A, Chakravarti R, Singh R, Bhattacharya B, Ghosh A, Bhutia SK, Ravichandiran V, Ghosh D. “A Review on the Current Status of Homeopathy in the Clinical Management of Cancer”. Current Drug Targets. (2022) (IF – 3.2)
  5. Singh R, Chandel S, Ghosh A, Gautam A, Huson DH, Ravichandiran V, Ghosh D. “Easy efficient HDR-based targeted knock-in in Saccharomyces cerevisiae genome using CRISPR-Cas9 system”. Bioengineered. (2022) (IF – 4.6)
  6. Gupta R, Ghosh A, Chakravarti R, Singh R, Ravichandiran V, Swarnakar S, Ghosh D. “Cas13d: A New Molecular Scissor for Transcriptome Engineering”. Frontiers in Cell and Developmental Biology. (2022) (IF – 5.5)
  7. Ghosh A, Gautam A, Gupta R, Singh R, Velayutham R, Ghosh D, Roy S. “An insight into SARS-CoV2 structure, Pathogenesis, target hunting for drug development and vaccine initiatives”. RSC Medicinal Chemistry. (2022) (IF – 5.5)
  8. Gupta R, Kazi TA, Dey D, Ghosh A, Ravichandiran V, Swarnakar S, Roy S, Biswas SR, Ghosh D. “CRISPR detectives against SARS-CoV-2: a major setback against COVID-19 blowout”. Applied Microbiology and Biotechnology. (2021) (IF – 4.1)
  9. Chakravarti R, Singh R, Ghosh A, Dey D, Sharma P, Velayutham R, Roy S, Ghosh D. “A review on potential of natural products in the management of COVID-19”. RSC Advances. (2021) (IF – 3.9)
  10. Ghosh A, Roychowdhury T, Nandi R, Maiti R, Ghosh NN, Molla SA, Mukhopadhyay S, Prodhan C, Chaudhury K, Das P, Sarkar NK, Chattopadhyay S, Bhattacharya R, Bose CK and Maiti DK. "Inhibitory role of smart nano-trifattyglyceride of Moringa oleifera-root in ovarian cancer by attenuating FSHR-c-Myc axis." Journal of Traditional and Complementary Medicine (2021). (IF – 4.5)
  11. Singh R, Gautam A, Chandel S, Sharma V, Ghosh A, Dey D, Roy S, Velayutham R, and Ghosh D. "Computational screening of FDA approved drugs of fungal origin that may interfere with SARS-CoV-2 spike protein activation, viral RNA replication, and post‐translational modification: a multiple target approach." In silico pharmacology (2021). (IF – NA)
  12. Singh R, Chandel S, Ghosh A, Dey D, Chakravarti R, Roy S, Velayutham R, and Ghosh D. "Application of CRISPR/Cas System in the Metabolic Engineering of Small Molecules." Molecular Biotechnology (2021). (IF – 2.6)
  13. Singh R, Gautam A, Chandel S, Ghosh A, Dey D, Roy S, Velayutham R, and Ghosh D. "Protease Inhibitory Effect of Natural Polyphenolic Compounds on SARS-CoV-2: An In Silico Study." Molecules (2020). (IF – 4.6)
  14. Singh R, Chandel S, Dey D, Ghosh A, Roy S, Velayutham Velayutham R, and Ghosh D. "Epigenetic modification and therapeutic targets of diabetes mellitus." Bioscience Reports (2020). (IF – 4.0)
  15. Ghosh A, Roy R, Nandi M, Mukhopadhyay A. “Scorpion Venom–Toxins that Aid in Drug Development: A Review”. International journal of peptide research and therapeutics (2019). (IF – 2.5)
  16. Ghosh A, Basak J, Mukhopadhyay A. “Coexistence of Rare Variant Hbd Punjab [α2β2121 (Glu→Gln)] And Alpha 3.7 Kb Deletion in a Young Boy of Hindu Family in West Bengal, India”. Cellular and Molecular Biology Letters (2015). (IF – 8.3)

 

ABSTRACTS AND PRESENTATIONS:

 

  1. Ghosh A, Dutta A, Sarkar T, Mukhopadhyay S. Evaluating the correlation of high CD38 expression and aberrant CD Markers with prognosis in Acute Leukemia: A study from Eastern India. MPAICON 2024, New Delhi. 2024
  2. Ghosh A, Roychowdhury T, Nandi R, Maiti R, Ghosh N N, Molla S, Mukhopadhyay S, Prodhan C, Chaudhury K, Das P, Sarkar N K, Chattopadhyay S, Bhattacharya R , Bose CK, Maiti D K. Robust antiproliferative efficacy of a novel nanotrifattyglyceride isolated from the root of Moringa oleifera Lam., in vitro, in vivo studies. NIOS 2024, Kolkata. 2024
  3. Ghosh A, Dutta A, Sarkar T, Mukherjee A, Mukhopadhyay H, Ghosh RD, Bhattacharya R, Mukhopadhyay S. Aberrant expression of CD Markers in Acute Leukemia: An eight month study in Netaji Subhas Chandra Bose cancer Hospital. NIOS 2023, Kolkata. 2023
  4. Sarkar T, Ghosh A, Mandal S, Bhattacharya R, Roy U, Basu S, Mukhopadhyay S. Antiproliferative effect of Inula recemosa root extract in hepatocellular carcinoma. Netaji Subhas Chandra Cancer Hospital. NIOS 2023, Kolkata. 2023
  5. Ghosh(Sarkar) T , Mukherjee A, Nag B, Ghosh A, Mondal S, Bhattacharyya R, Mukhopadhyay S. Anticancer activity of Inula recemosa root extract in human liver cancer cell line by attenuation of OCT4/Sox2 axis. ESMO Targeted Anticancer Therapies Congress 2023, Paris, France. 2023
  6. Sarkar T, Ghosh A, Mandal S, Bhattacharya R, Roy U, Basu S, Mukhopadhyay S, Antiproliferative effect of Inula recemosa root extract in hepatocellular carcinoma. NIOS 2023, India. 2023
  7. Ghosh A, Dutta A, Sarkar T, Mukherjee A, Mukhopadhyay H, Ghosh RD, Bhattacharya R, Mukhopadhyay S. Aberrant expression of CD Markers in Acute Leukemia: An eight month study in Netaji Subhas Chandra Bose cancer Hospital. NIOS 2023, India. 2023
  8. Ghosh A, Roychowdhury T, Nandi R, Maiti R, Ghosh NN, Molla SA, Mukhopadhyay S, Prodhan C, Chaudhury K, Das P, Sarkar NK, Chattopadhyay S, Bhattacharya R, Bose CK and Maiti DK.  Follicle stimulating hormone receptor (FSHR): a promising drug target for epithelial ovarian cancer. Rajabazar Science College, ICCHD, University of Calcutta, India. 2020
  9. Ghosh A, Bhattacharya D, Chatterjee K, Mukhopadhyay S, Mukhopadhyay A, Basak J. Carrier status of Beta and Alpha thalassemia in Kolkata and four adjacent districts. BESHCON 2019, India. 2019
  10. Ghosh A, Bhattacharya R, Pradhan C, Roychowdhury T, Chaudhuri K, Mandal S, Mukhopadhyay A, Bose CK. Antiproliferative effect of Moringa oleifera root extract on ovarian carcinoma: in vitro as well as in vivo study. PAC Young Scientist Award Lecture Professor Asima Chatterjee Centenary Celebration Symposium, India. 2018
  11. Datta A, Guha P (Chaudhuri) and Ghosh A. Palliative Care on Psychological Outcomes and Biomarkers among Lung Cancer Patients in Kolkata. The Asian Conference on Psychology& the Behavioural Sciences, Japan. 2018
  12. Ghosh A, Bhattacharya R, Pradhan C, Chaudhuri K, Mukhopadhyay A, CK Bose. Antiproliferative effect of Moringa oleifera root extract on ovarian carcinoma: an in vitro study. ESMO Asia 2016, Singapore. 2016
Name
Mobile
Location

Book Online